Increasing clinical evidence has also shown that tumor-infiltrating CD8+ lymphocytes (TILs) in the tumor environment is associated with survival of patients with cancer, further supporting the close relationship between immune escape and tumor microenvironment [20–22]. This evidence concerns the gene CD8A and neoplasm.